BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8057672)

  • 1. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
    Corey SJ; Locker J; Oliveri DR; Shekhter-Levin S; Redner RL; Penchansky L; Gollin SM
    Leukemia; 1994 Aug; 8(8):1350-3. PubMed ID: 8057672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
    Guidez F; Huang W; Tong JH; Dubois C; Balitrand N; Waxman S; Michaux JL; Martiat P; Degos L; Chen Z
    Leukemia; 1994 Feb; 8(2):312-7. PubMed ID: 8309256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
    Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
    Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
    Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
    J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF; Solomon E
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
    Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
    Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
    Laczika K; Mitterbauer G; Korninger L; Knöbl P; Schwarzinger I; Kapiotis S; Haas OA; Kyrle PA; Pont J; Oehler L
    Leukemia; 1994 Jan; 8(1):1-5. PubMed ID: 8289472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
    Wells RA; Hummel JL; De Koven A; Zipursky A; Kirby M; Dubé I; Kamel-Reid S
    Leukemia; 1996 Apr; 10(4):735-40. PubMed ID: 8618456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
    Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
    Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.
    Chen Z; Guidez F; Rousselot P; Agadir A; Chen SJ; Wang ZY; Degos L; Zelent A; Waxman S; Chomienne C
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1178-82. PubMed ID: 8302850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).
    Licht JD; Chomienne C; Goy A; Chen A; Scott AA; Head DR; Michaux JL; Wu Y; DeBlasio A; Miller WH
    Blood; 1995 Feb; 85(4):1083-94. PubMed ID: 7849296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Dejean A
    Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    Varghese L; Janckila A; Yam LT
    J Ky Med Assoc; 1999 Feb; 97(2):61-5. PubMed ID: 10073058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain.
    Sitterlin D; Tiollais P; Transy C
    Oncogene; 1997 Mar; 14(9):1067-74. PubMed ID: 9070655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse.
    Desangles F; Vilain E; Arborio M; De Revel T; Flandrin G
    Leuk Lymphoma; 1995 Sep; 19(1-2):185-8. PubMed ID: 8574167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.